Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: Effect of intensive antiinflammatory treatment

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 4, 2010, Pages 437-442

  Foster, Will ^a   Carruthers, David ^b   Lip, Gregory Y H ^a   Blann, Andrew D ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Endothelium; Inflammation; Rheumatoid arthritis; Soluble E selectin; Von willebrand factor

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ETANERCEPT; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; AUTACOID; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYTOKINE;

ADULT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE MARKER; DRUG MEGADOSE; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED;

EID: 77955447617     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0370-y     Document Type: Article

References (41)

1. Zvaifler NJ (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265-336. doi:10.1016/S0065-2776 (08) 60299-0
2. Scrivo R, Di Franco M, Spadaro A, Valesini G (2007) The immunology of rheumatoid arthritis. Ann N Y Acad Sci 1108:312-322. doi:10.1196/annals.1422.033 (Pubitemid 47528744)
3. Sfikakis PP, Tsokos GC (1997) Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases. Clin Diagn Lab Immunol 4:241-246
4. Blann AD, Herrick A, Jayson M I V (1995) Soluble adhesion molecules E-selectin, ICAM and VCAM in the inflammatory vasculitides: relationship with disease severity and established laboratory indices. Br J Rheumatol 34:814-819. doi:10.1093/rheumatology/34.9.814
5. Ziff M (1989) Role of endothelium in chronic inflammation. Springer Semin Immunopathol 11:199-214. doi:10.1007/BF00197189
6. Rothschild BM, Masi AT (1982) Pathogenesis of rheumatoid arthritis: a vascular hypothesis. Semin Arthritis Rheum 12:11-31. doi:10.1016/0049-0172 (82) 90020-8
7. Del Rincón I, O'Leary DH, Freeman GL, Escalante A (2007) Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 195:354-360. doi:10.1016/j.atheroscler osis.2006.09.027
8. Hannawi S, Haluska B, Marwick TH, Thomas R (2007) Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 9: R116. doi:10.1186/ar2323 (Pubitemid 350239078)
9. Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149-160. doi:10.1002/path.2287 (Pubitemid 351160153)
10. Smolen JS, Maini RN (2006) Interleukin-6: a new therapeutic target. Arthritis Res Ther 8 (Suppl 2): S5.
11. Erratum in: Arthritis Res Ther. 2006;8:407. doi:10.1186/ar1969
12. Maini RN, Brennan FM, Williams R, Chu CQ, Cope AP, Gibbons D, Elliott M, Feldmann M (1993) TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy. Clin Exp Rheumatol 11 (Suppl 8): S173-S175
13. Haskard DO (1995) Cell adhesion molecules in rheumatoid arthritis. Curr Opin Rheumatol 7:229-234. doi:10.1097/00002 281-199505000-00012
14. Tervaert JW, Kallenberg CG (1997) Cell adhesion molecules in vasculitis. Curr Opin Rheumatol 9:16-25
15. Volin MV (2005) Soluble adhesion molecules in the pathogenesis of rheumatoid arthritis. Curr Pharm Des 11:633-653. doi: 10.2174/1381612053381972 (Pubitemid 40277872)
16. Blann AD, Hopkins J, Winkles J, Wainwright AC (1992) Plasma and serum von Willebrand Factor antigen levels in connective tissue disorders. Ann Clin Biochem 29:67-71
17. Koch AE, Turkiewicz W, Harlow LA, Pope RM (1993) Soluble E-selectin in arthritis. Clin Immunol Immunopathol 69:29-35. doi:10.1006/clin. 1993.1146
18. Blann AD (2000) Viewpoint: endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis 11:623-630. doi:10.1097/00001721-200010000-00006
19. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V (1995) Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38:1122-1124. doi:10.1007/BF00402185
20. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD (1994) Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979-984
21. Blann AD, Tse W, Maxwell SJ, Waite MA (1994) Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 12:925-928. doi:10.1097/00004872-199408000-00010
22. Blann AD, McCollum CN (1994) Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 72:151-154
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324. doi:10.1002/art.1780310302
24. Emery P, Gabay C, Kraan M, Gomez-Reino J (2007) Evidencebased review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 27:793-806. doi:10.1007/s00296-007-0357-y (Pubitemid 46906651)
25. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS (2004) McG Thom S; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 18:139-185. doi:10.1038/sj.jhh.1001683 (Pubitemid 38425770)
26. British Cardiac Society, British Hypertension Society (2005) Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91 (Suppl 5): v1-v52. doi:10.1136/hrt.2005.079988 (Pubitemid 43021884)
27. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J (2001) Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens 19:1139-1147. doi:10.1097/00004872-200106000-00020 (Pubitemid 32493649)
28. Tokuhira M, Hosaka S, Volin MV, Haines G K III, Katschke KJ Jr, Kim S, Koch AE (2000) Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum 43:1122-1133. doi:10.1002/1529-0131 (200005) 43:5<1122::AID-ANR23>3.0. CO;2-7
29. Furuzawa-Carballeda J, Alcocer-Varela J (1999) Interleukin-8, interleukin-10, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis. Scand J Immunol 50:215-222. doi:10.1046/j.1365-3083. 1999.00573.x
30. Kraan MC, Reece RJ, Barg EC, Smeets TJ, Farnell J, Rosenburg R, Veale DJ, Breedveld FC, Emery P, Tak PP (2000) Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers. Arthritis Rheum 43:1820-1830. doi:10.1002/1529-0131 (200008) 43:8<1820::AID-ANR18>3.0. CO;2-D
31. Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL (1997) A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 36:164-169. doi:10.1093/rheumatology/36.2.164
32. Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7: R634-R643. doi: 10.1186/ar1717
33. Marlor CW, Webb DL, Bombara MP, Greve JM, Blue ML (1992) Expression of vascular cell adhesion molecule-1 in fibroblast like synoviocytes after stimulation with tumor necrosis factor. Am J Pathol 140:1055-1060
34. Paleolog EM, Crossman DC, McVey JH, Pearson JD (1990) Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 75:688-695
35. van der Poll T, van Deventer SJ, Pasterkamp G, van Mourik JA, Büller HR, ten Cate JW (1992) Tumor necrosis factor induces von Willebrand factor release in healthy humans. Thromb Haemost 67:623-626
36. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE (1991) Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 147:4398-4401
37. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ, Buurman WA (1992) E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77:543-549
38. Couffinhal T, Duplàa C, Labat L, Lamaziere JM, Moreau C, Printseva O, Bonnet J (1993) Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb 13:407-414
39. Scott DA, Stapleton JA, Wilson RF, Sutherland G, Palmer RM, Coward PY, Gustavsson G (2000) Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking. Blood Cells Mol Dis 26:255-258. doi:10.1006/bcmd.2000.0304
40. Blann AD, Steele C, McCollum CN (1997) The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost 78:1093-1096
41. Salat C, Boekstegers P, Holler E, Werdan K, Reinhardt B, Fateh-Moghadam S, Pihusch R, Kaul M, Beinert T, Hiller E (1996) Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodies. Shock 6:233-237. doi:10.1097/000 24382-199610000-00001